BULGHERONI, ELISABETTA
BULGHERONI, ELISABETTA
Universita' degli Studi di MILANO
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects
2002-02-01 S. Rusconi, E. Bulgheroni, S. La Seta-Catamancio, F.G. Croce, M. Lo Cicero, P.M. Citterio, M. Galli
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates
2004-03-01 E. Bulgheroni, P. Citterio, F. Croce, M. Lo Cicero, O. Viganò, F. Soster, T.C. Chou, M. Galli, S. Rusconi
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection : in vitro studies of mixed virus infections
2000-10-01 S. Rusconi, S. La Seta Catamancio, P. Citterio, E. Bulgheroni, F. Croce, S.H. Herrmann, RE.O fford, M. Galli, M.S. Hirsch
Entry and fusion inhibitors of HIV
2004-01-01 S. Rusconi, E. Bulgheroni, P. Citterio
In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate
1997-09-01 S. Rusconi, M. DePasquale, L. Milazzo, E. Bulgheroni, P.M. Citterio, S. Kurtagic, A. d' Arminio Monforte, M. Galli
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs
2000-09-01 S. Rusconi, D.P. Merrill, S. La Seta Catamancio, P. Citterio, E. Bulgheroni, F. Croce, T.C. Chou, O.O. Yang, S.H. Herrmann, M. Galli, M.S. Hirsch
In vitro inhibition of HIV-1 by Met-SDF-1β alone or in combination with antiretroviral drugs
2000-01-01 S. Rusconi, D.P. Merrill, S. La Seta Catamancio, P. Citterio, E. Bulgheroni, F. Croce, T.-. Chou, O.O. Yang, S.H. Herrmann, M. Galli, M.S. Hirsch
Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation
2013-09-26 P. De Candia, A. Torri, T. Gorletta, M. Fedeli, E. Bulgheroni, C. Cheroni, F. Marabita, M. Crosti, M. Moro, E. Pariani, L. Romanò, S. Esposito, F. Mosca, G. Rossetti, R.L. Rossi, J. Geginat, G. Casorati, P. Dellabona, M. Pagani, S. Abrignani
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure
1998-01-01 S. Rusconi, M. De Pasquale, L. Milazzo, S. Kurtagic, E. Bulgheroni, P.M. Citterio, M. Galazzi, S. La Seta-Catamancio, M. Galli
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility : evidence of a selective haploinsufficiency gene effect
2013-02-01 M. Sala, D. Braida, A. Donzelli, R. Martucci, M. Busnelli, E. Bulgheroni, T. Rubino, D. Parolaro, K. Nishimori, B. Chini
Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells
2016-01-01 S. Harari, D. Elia, O. Torre, E. Bulgheroni, E. Provasi, J. Moss
Unusual codon 69 insertions : influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility
2004-01-01 E. Bulgheroni, F. Croce, P. Citterio, O. Viganò, R. Visonà, E. Sala, M. Galli, S. Rusconi
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine
2001-03-01 S. Rusconi, S. La Seta Catamancio, P. Citterio, E. Bulgheroni, S. Kurtagic, M. Galazzi, F. Croce, M. Moroni, M. Galli